SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Predictive Oncology Inc. (AGPU) (CIK 0001446159) (AGPU) — Oct 15, 2009

Predictive Oncology Inc. (AGPU) (CIK 0001446159)
Date: Oct. 15, 2009 · CIK: 0001446159 · Accession: 0001144204-09-053062

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-155299

Date
Oct. 15, 2009
Author
Chief
Form
CORRESP
Company
Predictive Oncology Inc. (AGPU) (CIK 0001446159)

Letter

Unassociated Document

BioDrain Medical, Inc.

Centre Pointe Boulevard, Suite 7

Mendota Heights, Minnesota 55120

October 15, 2009

VIA FACSIMILE AND EDGAR

Securities and Exchange Commission

450 Fifth Street, N. W.

Washington, D.C. 20549

Re:

BioDrain Medical, Inc.

Registration Statement – Form S-1 (Registration No. 333-155299)

Ladies and Gentlemen:

BioDrain Medical, Inc.. (the “Company”) hereby requests that the Commission take appropriate action to cause the above-referenced registration statement on Form S-1 to become effective on October 19, 2009 at 9:00 a.m. Washington, D.C. time.

Very
truly yours,
BIODRAIN MEDICAL, INC.

Show Raw Text
CORRESP
1
filename1.htm

    Unassociated Document

    BioDrain
Medical, Inc.

    2060
Centre Pointe Boulevard, Suite 7

    Mendota
Heights, Minnesota 55120

    October
15, 2009

    VIA FACSIMILE AND
EDGAR

    Securities
and Exchange Commission

    450 Fifth
Street, N. W.

    Washington,
D.C. 20549

                Re:

                BioDrain Medical,
      Inc.

                Registration
      Statement – Form S-1 (Registration No.
  333-155299)

    Ladies
and Gentlemen:

    BioDrain
Medical, Inc.. (the “Company”) hereby requests that the Commission take
appropriate action to cause the above-referenced registration statement on Form
S-1 to become effective on October 19, 2009 at 9:00 a.m. Washington, D.C.
time.

                Very
      truly yours,

                BIODRAIN MEDICAL, INC.

                By:

              /s/ Kevin
      Davidson

              Kevin
      Davidson

                Chief
      Executive Officer